This included interventions for HFpEF and atrial fibrillation aimed at reducing pulmonary congestion, decreasing sympathetic drive, lowering left ventricular afterload, and controlling heart rate using diuretics, angiotensin-converting enzyme inhibitors, and antiarrhythmic medications [3,7]. This evidence concerns the gene ACE and pulmonary vascular congestion.